Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1685842

registered interest
date	30/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Shortages
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to tackle medicine shortages.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	12074
answer	answer is ministerial correction date of answer 05/02/2024 answer text <p>There are around 14,000 licensed medicines and the overwhelming majority are in good supply. However, the medicine supply chain is highly regulated, complex, and global, meaning there can sometimes be supply issues which affect the United Kingdom, along with other countries around the world.</p><p>Medicine supply problems can occur for several reasons such as manufacturing difficulties, regulatory non-compliance, access to raw materials, sudden demand spikes or distribution issues.</p><p>While it is not always possible to prevent supply issues from occurring, there is a team within the Department that has a range of well-established tools and processes to manage them when they arise, working closely with the pharmaceutical industry, the National Health Service, the Medicines and Healthcare products Regulatory Agency and others operating in the supply chain to help mitigate the risks to patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 05/02/2024 15:39:06 answering member 4044 label Biography information for Andrew Stephenson previous answer version 15319 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
tabling member	4623 label Biography information for Tonia Antoniazzi

1683706

registered interest
date	19/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the list of medical conditions which meet the criteria for a medical exemption certificate.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	10653
answer	answer is ministerial correction date of answer 26/01/2024 answer text <p>Approximately 89% of prescriptions are dispensed free of charge. People on a low income who do not qualify for an exemption from prescription charges can seek help under the NHS Low Income Scheme, which provides help with health costs on an income-related basis. For those who do not qualify for an exemption, prescription prepayment certificates (PPCs) allow people to obtain as many prescriptions as they need for a set cost. A three-monthly PPC or an annual PPC will save people money if they need four or more items in three months or <ins class="ministerial">12</ins> <del class="ministerial">13</del> or more items in 12 months.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 26/01/2024 09:57:19 question first ministerially corrected 01/02/2024 15:51:08 answering member 4117 label Biography information for Andrea Leadsom previous answer version 13571 answering member constituency South Northamptonshire answering member printed Andrea Leadsom answering member 4117 label Biography information for Andrea Leadsom
tabling member	4623 label Biography information for Tonia Antoniazzi

1586651

registered interest
date	17/02/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Cygnet Healthcare
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the average daily cost to the NHS was for a person receiving mental health support in a hospital ward owned by Cygnet Health Care in the latest period for which data is available.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	147363
answer	answer is ministerial correction date of answer 22/02/2023 answer text <p>The information requested is not held centrally.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 22/02/2023 16:50:48 answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1437552

registered interest
date	02/03/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to prepare for the implementation of the UK NSC’s recommendation on lung cancer screening.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	133255
answer	answer is ministerial correction date of answer 07/03/2022 answer text <p>The UK National Screening Committee (UK NSC) plans to open a three-month public consultation on the evidence for lung cancer screening in the week commencing 7 March 2022. The Department will receive the UK NSC’s recommendation on lung cancer screening in individuals at an increased risk following its meeting in June 2022.</p><p>If recommended, NHS England and NHS Improvement will be responsible for implementing the programme in England and preparatory work is underway.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 07/03/2022 11:40:55 answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1437553

registered interest
date	02/03/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to COVID-19 Response: Living with COVID-19, published on 21 February 2022, what steps his Department are taking to help ensure that NHS England's Targeted Lung Health Check programme is able to return to and exceed its pre-pandemic levels of performance.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	133256
answer	answer is ministerial correction date of answer 07/03/2022 answer text <p>All Targeted Lung Health Check (TLHC) sites were operational by September 2020 and are issuing in excess of 30,000 invitations each month, compared to 1,555 each month prior to the pandemic. In 2022/23, the number of operational THLCs sites will increase from 23 to 43, funded by up to £70 million from the NHS Cancer Programme. The UK National Screening Committee is currently considering whether TLHCs should be recommended as a national screening programme.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 128399 128400 question first answered 07/03/2022 15:58:08 answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1437133

registered interest
date	01/03/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Epilepsy: Cannabis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason only three NHS prescriptions for medical cannabis have been issued to children with severe intractable epilepsy since the law was changed in November 2018 to enable those prescriptions to be made in specialist cases.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	132342
answer	answer is ministerial correction date of answer 08/03/2022 answer text <p>The licensed cannabis-based medicine Epidyolex is prescribed and routinely funded by the National Health Service for two rare forms of epilepsy - Dravet syndrome and Lennox-Gastaut syndrome.</p><p>Clinical guidelines from the National Institute for Health and Care Excellence demonstrate a need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based products for medicinal use. We continue to call on manufacturers to conduct this research and we are working with regulatory, research and NHS partners to establish clinical trials to test the safety and efficacy of these products.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 08/03/2022 09:07:39 answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1434765

registered interest
date	23/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his timeline is for approval of the national lung cancer screening programme following its suspension in March 2020 due to the covid-19 outbreak.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	128399
answer	answer is ministerial correction date of answer 07/03/2022 answer text <p>All Targeted Lung Health Check (TLHC) sites were operational by September 2020 and are issuing in excess of 30,000 invitations each month, compared to 1,555 each month prior to the pandemic. In 2022/23, the number of operational THLCs sites will increase from 23 to 43, funded by up to £70 million from the NHS Cancer Programme. The UK National Screening Committee is currently considering whether TLHCs should be recommended as a national screening programme.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 128400 133256 question first answered 07/03/2022 15:58:08 answering member 4492 label Biography information for Maria Caulfield previous answer version 53980 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1434766

registered interest
date	23/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, on what date will the lung screening pilots in England recommence following their suspension in March 2020.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	128400
answer	answer is ministerial correction date of answer 07/03/2022 answer text <p>All Targeted Lung Health Check (TLHC) sites were operational by September 2020 and are issuing in excess of 30,000 invitations each month, compared to 1,555 each month prior to the pandemic. In 2022/23, the number of operational THLCs sites will increase from 23 to 43, funded by up to £70 million from the NHS Cancer Programme. The UK National Screening Committee is currently considering whether TLHCs should be recommended as a national screening programme.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 128399 133256 question first answered 07/03/2022 15:58:08 answering member 4492 label Biography information for Maria Caulfield previous answer version 53981 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi

1434203

registered interest
date	22/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Education England: Finance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what budget his Department has allocated to Health Education England for workforce growth and medical education in the financial year 2022-23.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	127510
answer	answer is ministerial correction date of answer 25/02/2022 answer text <p>Health Education England’s (HEE) budget for 2022/23 will be announced prior to 1 April 2022.</p><p>Spending plans for individual budgets, including for HEE’s budgets for workforce growth and medical education from 2022/23 to 2024/25, will be subject to a detailed financial planning exercise and finalised in due course.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 25/02/2022 14:53:38 answering member 4362 label Biography information for Edward Argar
tabling member	4623 label Biography information for Tonia Antoniazzi

1434207

registered interest
date	22/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Government's response to the Health and Social Care Select Committee’s report on Drugs Policy: Medicinal Cannabis, published in September 2019, what steps his Department has taken with the National Institute for Health Research to develop alternative research approaches to support children who are currently receiving cannabis-based products for medicinal use rather than randomised control trials, as set out in that response.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	127511
answer	answer is ministerial correction date of answer 25/02/2022 answer text <p>Research funding can be accessed through applications to the National Institute for Health Research (NIHR). The NIHR relies on researchers submitting high-quality applications and welcomes research proposals to evaluate the safety and clinical efficacy of cannabis-based products for medicinal use. The NIHR and the Medicines and Healthcare products Regulatory Agency (MHRA) will consider novel trial designs and it is not a specific requirement to conduct double blind trials. The MHRA has recently published guidance on the use of real-world data in clinical studies to support regulatory decisions.</p><p>The NIHR and the National Health Service will be supporting two randomised controlled trials into epilepsy. Alternative research approaches, such as an observational study, were considered in the trial design but discounted as it would not produce robust results nor add to the current evidence base.</p><p>In 2018, NHS England asked the British Paediatric Neurology Association (BPNA) to develop interim guidance for clinicians in the use and prescription of cannabis‐based products for medicinal use in children and young people with epilepsy. The National Institute for Health and Care Excellence (NICE) then published guidelines covering prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy. The BPNA has subsequently updated their guidance. As with all decisions to prescribe medicines, the General Medical Council expects doctors to use their professional judgement when deciding to what extent any clinical guidance is relevant.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 127512 127513 question first answered 25/02/2022 14:51:45 answering member 4492 label Biography information for Maria Caulfield
tabling member	4623 label Biography information for Tonia Antoniazzi